imatinib mesylate has been researched along with Dysphagia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berry, AC; Munoz, JC; Nakshabendi, R | 1 |
Kim, DK; Kim, YH; Lee, HJ; Park, SI | 1 |
2 other study(ies) available for imatinib mesylate and Dysphagia
Article | Year |
---|---|
A plunging case of intermittent dysphagia.
Topics: Aged; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Chemotherapy, Adjuvant; Deglutition Disorders; Endoscopy, Gastrointestinal; Endosonography; Esophageal Neoplasms; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Neoadjuvant Therapy; Piperazines; Protein Kinase Inhibitors; Pyrimidines | 2015 |
Surgical resection of esophageal gastrointestinal stromal tumors.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Deglutition Disorders; Esophageal Neoplasms; Esophagectomy; Female; Follow-Up Studies; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Male; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Pyrimidines; Retrospective Studies; Thoracotomy; Treatment Outcome | 2009 |